tirzepatide as compared with semaglutide vs semaglutide: A new battle in obesity treatment Semaglutide vs. Tirzepatide for weight
Description
Visceral Fat A large gut is caused by more than just the "pinchable" fat you can feel under your skin
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management under the brand name Mounjaro and for chronic weight management as Zepbound
It's particularly helpful for individuals with type 2 diabetes, high blood pressure, or cholesterol issues
Tirzepatide-treated participants lost weight in a ratio of 75% fat mass to 25% lean mass
Some people start losing 1 to 2 pounds per week
The gastrointestinal system is highly integrated with the central nervous system (CNS)
